Henry Schein, Inc. (NASDAQ:HSIC) Shares Acquired by Siemens Fonds Invest GmbH

Siemens Fonds Invest GmbH boosted its position in Henry Schein, Inc. (NASDAQ:HSIC) by 282.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,366 shares of the company’s stock after buying an additional 9,870 shares during the quarter. Siemens Fonds Invest GmbH’s holdings in Henry Schein were worth $925,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Invesco Ltd. lifted its holdings in Henry Schein by 0.4% during the 4th quarter. Invesco Ltd. now owns 4,963,409 shares of the company’s stock worth $343,468,000 after buying an additional 17,552 shares during the last quarter. FMR LLC raised its stake in shares of Henry Schein by 6.6% during the fourth quarter. FMR LLC now owns 3,498,033 shares of the company’s stock valued at $242,064,000 after purchasing an additional 217,143 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Henry Schein by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company’s stock valued at $218,762,000 after acquiring an additional 14,876 shares in the last quarter. Palestra Capital Management LLC acquired a new position in Henry Schein during the fourth quarter worth about $182,988,000. Finally, Fiduciary Management Inc. WI raised its holdings in shares of Henry Schein by 7.2% in the 4th quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company’s stock worth $172,193,000 after purchasing an additional 167,990 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

HSIC has been the topic of a number of research reports. Wells Fargo & Company dropped their target price on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 6th. StockNews.com lowered Henry Schein from a “buy” rating to a “hold” rating in a research note on Thursday, April 17th. UBS Group decreased their price target on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Jefferies Financial Group raised their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Finally, Barrington Research cut their price target on shares of Henry Schein from $90.00 to $86.00 and set an “outperform” rating for the company in a research note on Tuesday, May 6th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $79.30.

Insiders Place Their Bets

In related news, CEO Bradford C. Connett sold 4,036 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the transaction, the chief executive officer now owns 62,688 shares in the company, valued at $4,460,251.20. The trade was a 6.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the company’s stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. This represents a 9.50% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.08% of the company’s stock.

Henry Schein Stock Performance

NASDAQ:HSIC opened at $72.05 on Friday. The stock has a market capitalization of $8.77 billion, a P/E ratio of 29.65, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The firm has a 50 day moving average of $67.34 and a 200-day moving average of $71.46.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.04. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s revenue for the quarter was down .1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.10 EPS. As a group, sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.